✦ LIBER ✦

Mutation abundance affects the efficacy of EGFR tyrosine kinase inhibitor readministration in non-small-cell lung cancer with acquired resistance

✍ Scribed by Zhao, Ze-Rui; Wang, Jin-Feng; Lin, Yong-Bin; Wang, Fang; Fu, Sha; Zhang, Shu-Lin; Su, Xiao-Dong; Jiang, Long; Zhang, Yi-Gong; Shao, Jian-Yong; Long, Hao

Book ID: 121577996
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 328 KB
Volume: 31
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-013-0810-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Readministration of EGFR Tyrosine Kinase

Readministration of EGFR Tyrosine Kinase Inhibitor in Non-small Cell Lung Cancer Patients after Initial Failure, What Affects its Efficacy?

✍ Zhao, Ze-Rui; li, Wei; Long, Hao 📂 Article 📅 2014 🏛 Springer Science and Business Media LLC 🌐 English ⚖ 296 KB

Efficacy analysis of tyrosine kinase inh

Efficacy analysis of tyrosine kinase inhibitors on rare non-small cell lung cancer patients harboring complex EGFR mutations

✍ Peng, Liang; Song, Zhi-Gang; Jiao, Shun-Chang 📂 Article 📅 2014 🏛 Springer Science and Business Media LLC 🌐 English ⚖ 224 KB

Activating and resistance mutations of E

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

✍ Gazdar, A F 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 213 KB

Efficacy of EGFR Tyrosine Kinase Inhibit

Efficacy of EGFR Tyrosine Kinase Inhibitors in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer: A Meta-Analysis of 13 Randomized Trials

✍ Fausto Petrelli; Karen Borgonovo; Mary Cabiddu; Sandro Barni 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 473 KB

Volumetric tumor growth in advanced non-

Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy

✍ Nishino, Mizuki; Dahlberg, Suzanne E.; Cardarella, Stephanie; Jackman, David M.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Subsequent Chemotherapy Improves Surviva

Subsequent Chemotherapy Improves Survival Outcome in Advanced Non–Small-Cell Lung Cancer With Acquired Tyrosine Kinase Inhibitor Resistance

✍ Chih-Hsi Kuo; Shu-Min Lin; Kang-Yun Lee; Fu-Tsai Chung; Meng-Heng Hsieh; Yueh-Fu 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 338 KB